Development of a Novel Methodology Using BMVC Staining as an Assistance to Cancer Cytological Diagnosis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01301690

Enrollment

100

Registered

2011-02-23

Start date

2010-01-31

Completion date

Unknown

Last updated

2011-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Mass

Keywords

neck mass, ultrasound, FNA, BMVC

Brief summary

3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC) is an inorganic chemical compound (Figure1). The uptake of BMVC in cancer cells and normal cells are different. Recently, a simple handheld device (Figure1) based on the fluorescence analysis of stained cells was established to instantly differentiate cancer cells from normal cells. The investigators want to quantitatively measure the fluorescence expression of BMVC in normal and cancer cells and explore the usefulness of this staining in head and neck lumps.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* patients (age range from 18 to 90 years old) with neck lumps, receiving sonographic examination and FNA cytologic study.

Exclusion criteria

* No cytology data

Countries

Taiwan

Contacts

Primary ContactLi-Jen Liao, MD

deniro@mail2000.com.tw+886-0-8967-1592

Outcome results